Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats
Hypertension can be caused by various factors while the predominant causes include increase in body fluid volume and resistance in the circulatory system that elevate the blood pressure. Consumption of probiotics has been proven to attenuate hypertension; however, the effect is much strain-dependent...
Gespeichert in:
Veröffentlicht in: | The Korean journal of physiology & pharmacology 2016-01, Vol.20 (6), p.621-628 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | kor |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 628 |
---|---|
container_issue | 6 |
container_start_page | 621 |
container_title | The Korean journal of physiology & pharmacology |
container_volume | 20 |
creator | Yap, Wei Boon Ahmad, Faisal Malau Lim, Yi Cheng Zainalabidin, Satirah |
description | Hypertension can be caused by various factors while the predominant causes include increase in body fluid volume and resistance in the circulatory system that elevate the blood pressure. Consumption of probiotics has been proven to attenuate hypertension; however, the effect is much strain-dependent. In this study, a newly isolated Lactobacillus casei (Lb. casei ) strain C1 was investigated for its antihypertensive properties in spontaneously hypertensive rats (SHR). Lactic acid bacteria (LAB) suspension of 11 log colony-forming unit (CFU) was given to SHR (SHR+LAB, n=8), and phosphate buffer saline (PBS) was given as a control in SHR (SHR, n=8) and in Wistar rats as sham (WIS, n=8). The treatment was given via oral gavage for 8 weeks. The results showed that the weekly systolic blood pressure (SBP), mean arterial pressure (MAP), diastolic blood pressure (DBP) and aortic reactivity function were remarkably improved after 8 weeks of bacterial administration in SHR+LAB. These effects were mostly attributed by restoration of wall tension and tensile stress following the bacterial treatment. Although not statistically significant, the level of malondialdehye (MDA) in SHR+LAB serum was found declining. Increased levels of glutathione (GSH) and nitric oxide (NO) in SHR+LAB serum suggested that the bacterium exerted vascular protection through antioxidative functions and relatively high NO level that induced vasodilation. Collectively, Lb. casei strain C1 is a promising alternative for hypertension improvement. |
format | Article |
fullrecord | <record><control><sourceid>kyobo_kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO201634347490670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4050026486232</sourcerecordid><originalsourceid>FETCH-LOGICAL-k602-c844020ccc601922e0a1c9637340a8f16f0a6a3c2fe53589d99c362847742d383</originalsourceid><addsrcrecordid>eNpNzMtqwzAQhWFRWmho8w7adGkYz8iytAyh90A2WRbMWJEbEyMHjxzI2zfQLro68PNxbtQCwVNBDutbtSgRbWGqEu_VUqRvoSKqrav8Qn1tOOSx5dAPwyw6sMReS564T3pdas45pplzFH1mCfPAkw4HTt_XcBVyGlPmFMdZhos-XE5xunrpz1FPnOVR3XU8SFz-7YPavTzv1m_FZvv6vl5tiqMFLIIzBhBCCBZKjxiBy-At1WSAXVfaDtgyBexiRZXze-8DWXSmrg3uydGDevq9PfaS-ybtZWg-Vp9bhNKSIVMbD7aGf-4ytmPTjuMxxJTj1BioANAaZ5GQfgB7V1uO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats</title><source>KoreaMed Synapse</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Yap, Wei Boon ; Ahmad, Faisal Malau ; Lim, Yi Cheng ; Zainalabidin, Satirah</creator><creatorcontrib>Yap, Wei Boon ; Ahmad, Faisal Malau ; Lim, Yi Cheng ; Zainalabidin, Satirah</creatorcontrib><description>Hypertension can be caused by various factors while the predominant causes include increase in body fluid volume and resistance in the circulatory system that elevate the blood pressure. Consumption of probiotics has been proven to attenuate hypertension; however, the effect is much strain-dependent. In this study, a newly isolated Lactobacillus casei (Lb. casei ) strain C1 was investigated for its antihypertensive properties in spontaneously hypertensive rats (SHR). Lactic acid bacteria (LAB) suspension of 11 log colony-forming unit (CFU) was given to SHR (SHR+LAB, n=8), and phosphate buffer saline (PBS) was given as a control in SHR (SHR, n=8) and in Wistar rats as sham (WIS, n=8). The treatment was given via oral gavage for 8 weeks. The results showed that the weekly systolic blood pressure (SBP), mean arterial pressure (MAP), diastolic blood pressure (DBP) and aortic reactivity function were remarkably improved after 8 weeks of bacterial administration in SHR+LAB. These effects were mostly attributed by restoration of wall tension and tensile stress following the bacterial treatment. Although not statistically significant, the level of malondialdehye (MDA) in SHR+LAB serum was found declining. Increased levels of glutathione (GSH) and nitric oxide (NO) in SHR+LAB serum suggested that the bacterium exerted vascular protection through antioxidative functions and relatively high NO level that induced vasodilation. Collectively, Lb. casei strain C1 is a promising alternative for hypertension improvement.</description><identifier>ISSN: 1226-4512</identifier><identifier>EISSN: 2093-3827</identifier><language>kor</language><publisher>대한생리학회-대한약리학회</publisher><ispartof>The Korean journal of physiology & pharmacology, 2016-01, Vol.20 (6), p.621-628</ispartof><rights>COPYRIGHT(C) KYOBO BOOK CENTRE ALL RIGHTS RESERVED</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024</link.rule.ids></links><search><creatorcontrib>Yap, Wei Boon</creatorcontrib><creatorcontrib>Ahmad, Faisal Malau</creatorcontrib><creatorcontrib>Lim, Yi Cheng</creatorcontrib><creatorcontrib>Zainalabidin, Satirah</creatorcontrib><title>Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats</title><title>The Korean journal of physiology & pharmacology</title><addtitle>The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology</addtitle><description>Hypertension can be caused by various factors while the predominant causes include increase in body fluid volume and resistance in the circulatory system that elevate the blood pressure. Consumption of probiotics has been proven to attenuate hypertension; however, the effect is much strain-dependent. In this study, a newly isolated Lactobacillus casei (Lb. casei ) strain C1 was investigated for its antihypertensive properties in spontaneously hypertensive rats (SHR). Lactic acid bacteria (LAB) suspension of 11 log colony-forming unit (CFU) was given to SHR (SHR+LAB, n=8), and phosphate buffer saline (PBS) was given as a control in SHR (SHR, n=8) and in Wistar rats as sham (WIS, n=8). The treatment was given via oral gavage for 8 weeks. The results showed that the weekly systolic blood pressure (SBP), mean arterial pressure (MAP), diastolic blood pressure (DBP) and aortic reactivity function were remarkably improved after 8 weeks of bacterial administration in SHR+LAB. These effects were mostly attributed by restoration of wall tension and tensile stress following the bacterial treatment. Although not statistically significant, the level of malondialdehye (MDA) in SHR+LAB serum was found declining. Increased levels of glutathione (GSH) and nitric oxide (NO) in SHR+LAB serum suggested that the bacterium exerted vascular protection through antioxidative functions and relatively high NO level that induced vasodilation. Collectively, Lb. casei strain C1 is a promising alternative for hypertension improvement.</description><issn>1226-4512</issn><issn>2093-3827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>JDI</sourceid><recordid>eNpNzMtqwzAQhWFRWmho8w7adGkYz8iytAyh90A2WRbMWJEbEyMHjxzI2zfQLro68PNxbtQCwVNBDutbtSgRbWGqEu_VUqRvoSKqrav8Qn1tOOSx5dAPwyw6sMReS564T3pdas45pplzFH1mCfPAkw4HTt_XcBVyGlPmFMdZhos-XE5xunrpz1FPnOVR3XU8SFz-7YPavTzv1m_FZvv6vl5tiqMFLIIzBhBCCBZKjxiBy-At1WSAXVfaDtgyBexiRZXze-8DWXSmrg3uydGDevq9PfaS-ybtZWg-Vp9bhNKSIVMbD7aGf-4ytmPTjuMxxJTj1BioANAaZ5GQfgB7V1uO</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Yap, Wei Boon</creator><creator>Ahmad, Faisal Malau</creator><creator>Lim, Yi Cheng</creator><creator>Zainalabidin, Satirah</creator><general>대한생리학회-대한약리학회</general><general>The Korean Journal of Physiology & Pharmacology Editorial Office</general><scope>P5Y</scope><scope>SSSTE</scope><scope>JDI</scope></search><sort><creationdate>20160101</creationdate><title>Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats</title><author>Yap, Wei Boon ; Ahmad, Faisal Malau ; Lim, Yi Cheng ; Zainalabidin, Satirah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-k602-c844020ccc601922e0a1c9637340a8f16f0a6a3c2fe53589d99c362847742d383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yap, Wei Boon</creatorcontrib><creatorcontrib>Ahmad, Faisal Malau</creatorcontrib><creatorcontrib>Lim, Yi Cheng</creatorcontrib><creatorcontrib>Zainalabidin, Satirah</creatorcontrib><collection>Kyobo Scholar (교보스콜라)</collection><collection>Scholar(스콜라)</collection><collection>KoreaScience</collection><jtitle>The Korean journal of physiology & pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yap, Wei Boon</au><au>Ahmad, Faisal Malau</au><au>Lim, Yi Cheng</au><au>Zainalabidin, Satirah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats</atitle><jtitle>The Korean journal of physiology & pharmacology</jtitle><addtitle>The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>20</volume><issue>6</issue><spage>621</spage><epage>628</epage><pages>621-628</pages><issn>1226-4512</issn><eissn>2093-3827</eissn><abstract>Hypertension can be caused by various factors while the predominant causes include increase in body fluid volume and resistance in the circulatory system that elevate the blood pressure. Consumption of probiotics has been proven to attenuate hypertension; however, the effect is much strain-dependent. In this study, a newly isolated Lactobacillus casei (Lb. casei ) strain C1 was investigated for its antihypertensive properties in spontaneously hypertensive rats (SHR). Lactic acid bacteria (LAB) suspension of 11 log colony-forming unit (CFU) was given to SHR (SHR+LAB, n=8), and phosphate buffer saline (PBS) was given as a control in SHR (SHR, n=8) and in Wistar rats as sham (WIS, n=8). The treatment was given via oral gavage for 8 weeks. The results showed that the weekly systolic blood pressure (SBP), mean arterial pressure (MAP), diastolic blood pressure (DBP) and aortic reactivity function were remarkably improved after 8 weeks of bacterial administration in SHR+LAB. These effects were mostly attributed by restoration of wall tension and tensile stress following the bacterial treatment. Although not statistically significant, the level of malondialdehye (MDA) in SHR+LAB serum was found declining. Increased levels of glutathione (GSH) and nitric oxide (NO) in SHR+LAB serum suggested that the bacterium exerted vascular protection through antioxidative functions and relatively high NO level that induced vasodilation. Collectively, Lb. casei strain C1 is a promising alternative for hypertension improvement.</abstract><pub>대한생리학회-대한약리학회</pub><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1226-4512 |
ispartof | The Korean journal of physiology & pharmacology, 2016-01, Vol.20 (6), p.621-628 |
issn | 1226-4512 2093-3827 |
language | kor |
recordid | cdi_kisti_ndsl_JAKO201634347490670 |
source | KoreaMed Synapse; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
title | Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A48%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kyobo_kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lactobacillus%20casei%20strain%20C1%20attenuates%20vascular%20changes%20in%20spontaneously%20hypertensive%20rats&rft.jtitle=The%20Korean%20journal%20of%20physiology%20&%20pharmacology&rft.au=Yap,%20Wei%20Boon&rft.date=2016-01-01&rft.volume=20&rft.issue=6&rft.spage=621&rft.epage=628&rft.pages=621-628&rft.issn=1226-4512&rft.eissn=2093-3827&rft_id=info:doi/&rft_dat=%3Ckyobo_kisti%3E4050026486232%3C/kyobo_kisti%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |